|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 14/08 | CASI Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 14/08 | Casi Pharmaceuticals, Inc. Announces Management Changes | CI |
| Market Cap | 25.63L 22.62L 21.4L 19.41L 36.39L 25Cr 36.75L 2.57Cr 98.95L 13Cr 96.24L 94.15L 40Cr | P/E 2024 |
-1.11x | P/E 2025 | -0.33x |
|---|---|---|---|---|---|
| Enterprise Value | 2.44Cr 2.15Cr 2.04Cr 1.85Cr 3.47Cr 234.3Cr 3.5Cr 24Cr 9.43Cr 119.64Cr 9.17Cr 8.97Cr 385.02Cr | EV / Sales 2024 |
1.75x | EV / Sales 2025 | 1.9x |
| Free-Float |
53.46% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
David Cory
CEO | Chief Executive Officer | 62 | 21/07/2025 |
Kun Qian
DFI | Director of Finance/CFO | 44 | 16/05/2025 |
Chun Hua Wang
COO | Chief Operating Officer | 54 | 01/01/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Yue Wu
BRD | Director/Board Member | 62 | 01/04/2013 |
Zhen Bo Su
BRD | Director/Board Member | 50 | 21/03/2023 |
Thomas Folinsbee
BRD | Director/Board Member | 59 | 21/03/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.15% | +1.30% | +63.16% | +120.69% | 1,05600Cr | |
| -1.94% | -0.91% | +46.86% | +71.26% | 66TCr | |
| -0.94% | -0.61% | +18.11% | +76.83% | 47TCr | |
| -1.72% | -4.06% | +36.39% | +39.47% | 34TCr | |
| -0.40% | +3.83% | +22.08% | +28.82% | 28TCr | |
| -0.51% | -1.93% | +12.09% | +11.94% | 26TCr | |
| +0.99% | +2.67% | +53.73% | +56.71% | 23TCr | |
| -0.45% | -0.84% | +34.42% | +102.00% | 19TCr | |
| -0.24% | -2.76% | -28.41% | -60.92% | 17TCr | |
| Average | -0.60% | +0.97% | +28.72% | +49.64% | 40.48TCr | |
| Weighted average by Cap. | -0.72% | +1.04% | +38.83% | +70.44% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.85Cr 2.52Cr 2.38Cr 2.16Cr 4.05Cr 273.83Cr 4.09Cr 29Cr 11Cr 139.83Cr 11Cr 10Cr 449.98Cr | 2.07Cr 1.83Cr 1.73Cr 1.57Cr 2.94Cr 198.75Cr 2.97Cr 21Cr 8Cr 101.49Cr 7.78Cr 7.61Cr 326.59Cr |
| Net income | -3.93Cr -3.46Cr -3.28Cr -2.97Cr -5.57Cr -376.71Cr -5.63Cr -39Cr -15Cr -192.36Cr -15Cr -14Cr -619.03Cr | -4.81Cr -4.24Cr -4.01Cr -3.64Cr -6.82Cr -461.15Cr -6.89Cr -48Cr -19Cr -235.48Cr -18Cr -18Cr -757.79Cr |
| Net Debt | 60.5L 53.39L 50.52L 45.81L 85.89L 58Cr 86.74L 6.06Cr 2.34Cr 30Cr 2.27Cr 2.22Cr 95Cr | 2.19Cr 1.93Cr 1.82Cr 1.65Cr 3.1Cr 209.7Cr 3.13Cr 22Cr 8.44Cr 107.08Cr 8.21Cr 8.03Cr 344.6Cr |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
